ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 157 filers reported holding ZAI LAB LTD in Q1 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,277 | -17.0% | 29,382 | -5.3% | 0.00% | – |
| Q2 2023 | $860,712 | +15.3% | 31,039 | +27.7% | 0.00% | – |
| Q4 2022 | $746,194 | +46.9% | 24,306 | +63.5% | 0.00% | – |
| Q3 2022 | $508,000 | -82.9% | 14,863 | -78.0% | 0.00% | -100.0% |
| Q1 2022 | $2,974,000 | +9.3% | 67,608 | +56.2% | 0.00% | – |
| Q4 2021 | $2,722,000 | -84.1% | 43,290 | -73.4% | 0.00% | -100.0% |
| Q3 2021 | $17,164,000 | -30.9% | 162,855 | +16.0% | 0.01% | -22.2% |
| Q2 2021 | $24,841,000 | +323.4% | 140,351 | +219.2% | 0.01% | +200.0% |
| Q1 2021 | $5,867,000 | +327.3% | 43,973 | +333.4% | 0.00% | – |
| Q4 2020 | $1,373,000 | -33.3% | 10,146 | -59.0% | 0.00% | -100.0% |
| Q3 2020 | $2,059,000 | +258.1% | 24,753 | +253.6% | 0.00% | – |
| Q2 2020 | $575,000 | +96.2% | 7,000 | +22.9% | 0.00% | – |
| Q1 2020 | $293,000 | -58.6% | 5,696 | -84.3% | 0.00% | -100.0% |
| Q3 2018 | $707,000 | – | 36,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |